| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 14 |
| 1 | CARBIDOPA AND LEVODOPA | 10 |
| 2 | INFLIXIMAB | 9 |
| 3 | PANTOPRAZOLE | 8 |
| 4 | PREDNISONE | 8 |
| 5 | ERGOCALCIFEROL | 7 |
| 6 | AMLODIPINE | 6 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 6 |
| 8 | BEVACIZUMAB | 5 |
| 9 | CLONAZEPAM | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CALCIUM ANTACID | 1 | 0.0023 |
| 1 | NALOXONE HCL | 1 | 0.0012 |
| 2 | INFLIXIMAB-DYYB | 4 | 0.0012 |
| 3 | DORZOLAMIDE HCL | 1 | 0.0009 |
| 4 | OPICAPONE | 2 | 0.0008 |
| 5 | SAFINAMIDE MESYLATE | 1 | 0.0007 |
| 6 | ENTACAPONE | 2 | 0.0005 |
| 7 | TURMERIC | 2 | 0.0004 |
| 8 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 9 | TRIFLURIDINE AND TIPIRACIL | 4 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 1 | Nonergot Dopamine Agonist [EPC] | 3 | 0.0002 |
| 2 | Aromatic Amino Acid [EPC] | 11 | 0.0002 |
| 3 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 6 | 0.0001 |
| 5 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Sulfone [EPC] | 1 | 0.0001 |
| 7 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 8 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 9 | beta3-Adrenergic Agonist [EPC] | 3 | 0.0001 |